Health care stocks fell Monday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both shedding 0.6%.
The iShares Biotechnology ETF (IBB) rose 0.4%.
In corporate news, BioNTech (BNTX) expects full-year revenue at the low end of guidance due in part to inventory writedowns, even as variant-adapted COVID-19 vaccines helped boost Q3 results. The shares fell 0.7%.
PACS (PACS) shares tumbled 28% following a report by short-seller Hindenburg Research.
AstraZeneca (AZN) said its experimental obesity pill was well-tolerated by people with type-2 diabetes, Bloomberg reported, citing comments made by a company executive at an industry conference. AstraZeneca shares eased 0.2%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。